Publicaciones en colaboración con investigadores/as de Universidad de Alcalá (21)

2024

  1. Health service and psychotropic medication use for mental health conditions among healthcare workers active during the Spain Covid-19 Pandemic – A prospective cohort study using web-based surveys.

    Psychiatry Research, Vol. 334

2023

  1. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

  2. Traumatic stress symptoms among Spanish healthcare workers during the COVID-19 pandemic: a prospective study

    Epidemiology and psychiatric sciences, Vol. 32, pp. e50

2022

  1. Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic

    Journal of Psychiatric Research, Vol. 149, pp. 10-17

2021

  1. The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 164-176

2020

  1. Identifying key transcription factors for pharmacogenetic studies of antipsychotics induced extrapyramidal symptoms

    Psychopharmacology, Vol. 237, Núm. 7, pp. 2151-2159

  2. Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort

    Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552

  3. Social Cognition in Autism and Schizophrenia Spectrum Disorders: The Same but Different?

    Journal of Autism and Developmental Disorders, Vol. 50, Núm. 8, pp. 3046-3059

2019

  1. Author Correction: Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics (Translational Psychiatry, (2018), 8, 1, (276), 10.1038/s41398-018-0330-4)

    Translational Psychiatry

  2. One decade of the first episodes project (PEPs): Advancing towards a precision psychiatry

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 3, pp. 135-140

2018

  1. Improving pharmacogenetic prediction of extrapyramidal symptoms induced by antipsychotics

    Translational Psychiatry, Vol. 8, Núm. 1

  2. Smoking does not impact social and non-social cognition in patients with first episode psychosis

    Schizophrenia Research, Vol. 199, pp. 64-74

2017

  1. Cannabis use, COMT, BDNF and age at first-episode psychosis

    Psychiatry Research, Vol. 250, pp. 38-43

  2. Modelling gene-environment interaction in first episodes of psychosis

    Schizophrenia Research, Vol. 189, pp. 181-189

  3. Persistent negative symptoms in first-episode psychosis: Early cognitive and social functioning correlates and differences between early and adult onset

    Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. 1414-1422

2016

  1. A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project

    International Journal of Neuropsychopharmacology, Vol. 19, Núm. 4

  2. Age at first episode modulates diagnosis-related structural brain abnormalities in psychosis

    Schizophrenia Bulletin, Vol. 42, Núm. 2, pp. 344-357

  3. Opposite cannabis-cognition associations in psychotic patients depending on family history

    PLoS ONE, Vol. 11, Núm. 8

2015

  1. Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis: The PEPsCog Study

    Schizophrenia Research, Vol. 164, Núm. 1-3, pp. 65-73

2014

  1. Movie for the Assessment of Social Cognition (MASC): Spanish validation

    Journal of Autism and Developmental Disorders, Vol. 44, Núm. 8, pp. 1886-1896